Surprising drug combo could reshape treatment for suicide risk - The Washington Post
Surprising drug combo could reshape treatment for suicide risk The Washington PostDrug combo is the first to prolong ketamine’s antisuicide effects Stanford MedicineCombination therapy shows promise in maintaining lower suicidal thoughts over time News-MedicalNew Study Suggests Low-Dose Buprenorphine Enhances Ketamine’s Lasting Effects on Suicidal Ideation Bioengineer.org
